14-Jan-2025
RBC Capital Keeps Their Buy Rating on Avantor (AVTR)
TipRanks (Mon, 13-Jan 8:49 PM ET)
Morgan Stanley Remains a Buy on Avantor (AVTR)
TipRanks (Mon, 13-Jan 8:17 AM ET)
Avantor to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
PRNewswire (Fri, 10-Jan 8:05 AM ET)
Avantor to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
PRNewswire (Fri, 3-Jan 8:05 AM ET)
Avantor to Participate in the 7th Annual Evercore ISI HealthCONx Conference
PRNewswire (Wed, 20-Nov 8:05 AM ET)
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing Technology
Business Wire (Wed, 20-Nov 7:30 AM ET)
Avantor Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
PRNewswire (Thu, 14-Nov 8:05 AM ET)
Avantor Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors
PRNewswire (Wed, 6-Nov 8:05 AM ET)
Avantor Reports Third Quarter 2024 Results
PRNewswire (Fri, 25-Oct 6:05 AM ET)
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Avantor trades on the NYSE stock market under the symbol AVTR.
As of January 14, 2025, AVTR stock price declined to $21.72 with 4,067,487 million shares trading.
AVTR has a beta of 0.49, meaning it tends to be less sensitive to market movements. AVTR has a correlation of 0.04 to the broad based SPY ETF.
AVTR has a market cap of $14.78 billion. This is considered a Large Cap stock.
Last quarter Avantor reported $2 billion in Revenue and $.26 earnings per share. This fell short of revenue expectation by $-16 million and exceeded earnings estimates by $.01.
In the last 3 years, AVTR traded as high as $38.83 and as low as $16.63.
The top ETF exchange traded funds that AVTR belongs to (by Net Assets): IJH, VTI, VO, VXF, MDY.
AVTR has underperformed the market in the last year with a return of -1.3%, while the SPY ETF gained +23.6%. In the last 3 month period, AVTR fell short of the market, returning -13.3%, while SPY returned 0.0%. However, in the most recent 2 weeks AVTR has outperformed the stock market by returning +3.1%, while SPY returned -0.7%.
AVTR support price is $21.64 and resistance is $22.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVTR shares will trade within this expected range on the day.